Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
View ORCID ProfileLucie Loyal, Julian Braun, View ORCID ProfileLarissa Henze, Beate Kruse, Manuela Dingeldey, Ulf Reimer, View ORCID ProfileFlorian Kern, Tatjana Schwarz, Maike Mangold, Clara Unger, Friederike Dörfler, Shirin Kadler, Jennifer Rosowski, Kübrah Gürcan, Zehra Uyar-Aydin, Marco Frentsch, View ORCID ProfileFlorian Kurth, Karsten Schnatbaum, Maren Eckey, Stefan Hippenstiel, Andreas Hocke, Marcel A. Müller, Birgit Sawitzki, Stefan Miltenyi, Friedemann Paul, Marcus A. Mall, Holger Wenschuh, Sebastian Voigt, Christian Drosten, Roland Lauster, Nils Lachman, Leif-Erik Sander, Victor M. Corman, Jobst Röhmel, Lil Meyer-Arndt, View ORCID ProfileAndreas Thiel, View ORCID ProfileClaudia Giesecke-Thiel, the Charité Corona Cross Study Group
doi: https://doi.org/10.1101/2021.04.01.21252379
Lucie Loyal
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Julian Braun
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Larissa Henze
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Beate Kruse
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Manuela Dingeldey
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Ulf Reimer
3JPT Peptide Technologies GmbH, Berlin, Germany
Florian Kern
3JPT Peptide Technologies GmbH, Berlin, Germany
4Brighton and Sussex Medical School, Department of Clinical and Experimental Medicine, Brighton, UK
Tatjana Schwarz
5Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
6Charité - Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany
Maike Mangold
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Clara Unger
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Friederike Dörfler
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
Shirin Kadler
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
7Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany
Jennifer Rosowski
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
7Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany
Kübrah Gürcan
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
7Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany
Zehra Uyar-Aydin
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
7Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany
Marco Frentsch
8Charité - Universitätsmedizin Berlin, Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany
9Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Therapy-Induced Remodeling in Immuno-Oncology, Berlin, Germany
Florian Kurth
10Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
11Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & i. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Karsten Schnatbaum
3JPT Peptide Technologies GmbH, Berlin, Germany
Maren Eckey
3JPT Peptide Technologies GmbH, Berlin, Germany
Stefan Hippenstiel
10Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
Andreas Hocke
10Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
Marcel A. Müller
6Charité - Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany
Birgit Sawitzki
12Charité - Universitätsmedizin Berlin, Institute of Medical Immunology, Berlin, Germany
Stefan Miltenyi
13Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany
Friedemann Paul
14Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany
15Charité - Universitätsmedizin Berlin, Clinical Neuroimmunology, NeuroCure Clinical Research Center, Berlin, Germany
Marcus A. Mall
16Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
Holger Wenschuh
3JPT Peptide Technologies GmbH, Berlin, Germany
Sebastian Voigt
17Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany
Christian Drosten
5Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
6Charité - Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany
Roland Lauster
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
7Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany
Nils Lachman
18Charité - Universitätsmedizin Berlin, Institute for Transfusion Medicine, Tissue Typing Laboratory, Berlin, Germany
Leif-Erik Sander
10Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
Victor M. Corman
5Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
6Charité - Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany
Jobst Röhmel
16Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
Lil Meyer-Arndt
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
14Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany
15Charité - Universitätsmedizin Berlin, Clinical Neuroimmunology, NeuroCure Clinical Research Center, Berlin, Germany
19Charité - Universitätsmedizin Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany
Andreas Thiel
1Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany
2Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin (BCRT), Germany
Claudia Giesecke-Thiel
20Max Planck Institute for Molecular Genetics, Berlin, Germany
Data Availability
All raw data is shown in the supplementary figures or will be provided upon request.
Posted April 05, 2021.
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Lucie Loyal, Julian Braun, Larissa Henze, Beate Kruse, Manuela Dingeldey, Ulf Reimer, Florian Kern, Tatjana Schwarz, Maike Mangold, Clara Unger, Friederike Dörfler, Shirin Kadler, Jennifer Rosowski, Kübrah Gürcan, Zehra Uyar-Aydin, Marco Frentsch, Florian Kurth, Karsten Schnatbaum, Maren Eckey, Stefan Hippenstiel, Andreas Hocke, Marcel A. Müller, Birgit Sawitzki, Stefan Miltenyi, Friedemann Paul, Marcus A. Mall, Holger Wenschuh, Sebastian Voigt, Christian Drosten, Roland Lauster, Nils Lachman, Leif-Erik Sander, Victor M. Corman, Jobst Röhmel, Lil Meyer-Arndt, Andreas Thiel, Claudia Giesecke-Thiel, the Charité Corona Cross Study Group
medRxiv 2021.04.01.21252379; doi: https://doi.org/10.1101/2021.04.01.21252379
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Lucie Loyal, Julian Braun, Larissa Henze, Beate Kruse, Manuela Dingeldey, Ulf Reimer, Florian Kern, Tatjana Schwarz, Maike Mangold, Clara Unger, Friederike Dörfler, Shirin Kadler, Jennifer Rosowski, Kübrah Gürcan, Zehra Uyar-Aydin, Marco Frentsch, Florian Kurth, Karsten Schnatbaum, Maren Eckey, Stefan Hippenstiel, Andreas Hocke, Marcel A. Müller, Birgit Sawitzki, Stefan Miltenyi, Friedemann Paul, Marcus A. Mall, Holger Wenschuh, Sebastian Voigt, Christian Drosten, Roland Lauster, Nils Lachman, Leif-Erik Sander, Victor M. Corman, Jobst Röhmel, Lil Meyer-Arndt, Andreas Thiel, Claudia Giesecke-Thiel, the Charité Corona Cross Study Group
medRxiv 2021.04.01.21252379; doi: https://doi.org/10.1101/2021.04.01.21252379
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)